Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (41)
Yichen Zhong, Hakimeh Moghaddas Sani, Bishnu P. Paudel, Jason K. K. Low, Ana P. G. Silva, Stefan Mueller, Chandrika Deshpande, Santosh Panjikar, Xavier J. Reid, Max J. Bedward, Antoine M. van Oijen & Joel P. Mackay. (2022) The role of auxiliary domains in modulating CHD4 activity suggests mechanistic commonality between enzyme families. Nature Communications 13:1.
Crossref
Crossref
Miaomiao Jia, Xueqin Zou, Shuying Yin, Weihong Tian, Yangjing Zhao, Hui Wang, Guoying Xu, Weili Cai & Qixiang Shao. (2022) CHD4 orchestrates the symphony of T and B lymphocytes development and a good mediator in preventing from autoimmune disease. Immunity, Inflammation and Disease 10:7.
Crossref
Crossref
James D. Price, Susan Lindtner, Athena Ypsilanti, Fadya Binyameen, Jeffrey R. Johnson, Billy W. Newton, Nevan J. Krogan & John L. R. Rubenstein. (2022) DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. Development 149:11.
Crossref
Crossref
James R. Hagman, Tessa Arends, Curtis Laborda, Jennifer R. Knapp, Laura Harmacek & Brian P. O’Connor. (2021) Chromodomain helicase DNA‐binding 4 (CHD4) regulates early B cell identity and V(D)J recombination*. Immunological Reviews 305:1, pages 29-42.
Crossref
Crossref
Selami Demirci, Alexis Leonard, Khaled Essawi & John F. Tisdale. (2021) CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease. Molecular Therapy - Methods & Clinical Development 23, pages 276-285.
Crossref
Crossref
Andrej Alendar & Anton Berns. (2021) Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease. Genes & Development 35:21-22, pages 1403-1430.
Crossref
Crossref
Maria Sergeevna Protasova, Tatiana Vladimirovna Andreeva & Evgeny Ivanovich Rogaev. (2021) Factors Regulating the Activity of LINE1 Retrotransposons. Genes 12:10, pages 1562.
Crossref
Crossref
Apolonia Novillo, Ana Fernández-Santander, Maria Gaibar, Miguel Galán, Alicia Romero-Lorca, Fadoua El Abdellaoui-Soussi & Pablo Gómez-del Arco. (2021) Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Zi Wang, Pan Wang, Yanan Li, Hongling Peng, Yu Zhu, Narla Mohandas & Jing Liu. (2021) Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Roswitha Nast, Tenzin Choepak & Carsten G. K. Lüder. (2020) Epigenetic Control of IFN-γ Host Responses During Infection With Toxoplasma gondii. Frontiers in Immunology 11.
Crossref
Crossref
Wangang Gong, Maowei Ni, Zhongbo Chen & Zhiguo Zheng. (2020) Expression and clinical significance of methyl‑CpG binding domain protein 2 in high‑grade serous ovarian cancer. Oncology Letters 20:3, pages 2749-2756.
Crossref
Crossref
Yichen Zhong, Bishnu P. Paudel, Daniel P. Ryan, Jason K. K. Low, Charlotte Franck, Karishma Patel, Max J. Bedward, Mario Torrado, Richard J. Payne, Antoine M. van Oijen & Joel P. Mackay. (2020) CHD4 slides nucleosomes by decoupling entry- and exit-side DNA translocation. Nature Communications 11:1.
Crossref
Crossref
Rebecca Smith, Théo Lebeaupin, Szilvia Juhász, Catherine Chapuis, Ostiane D’Augustin, Stéphanie Dutertre, Peter Burkovics, Christian Biertümpfel, Gyula Timinszky & Sébastien Huet. (2019) Poly(ADP-ribose)-dependent chromatin unfolding facilitates the association of DNA-binding proteins with DNA at sites of damage. Nucleic Acids Research 47:21, pages 11250-11267.
Crossref
Crossref
Tessa ArendsCarissa DegeAlexandra BortnickThomas Danhorn, Jennifer R. KnappHaiqun JiaLaura HarmacekCourtney J. Fleenor, Desiree Straign, Kendra WaltonSonia M. Leach, Ann J. FeeneyCornelis MurreBrian P. O’Connor & James R. Hagman. (2019) CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesis. Proceedings of the National Academy of Sciences 116:22, pages 10927-10936.
Crossref
Crossref
Mark Morris. 2019. Clinical Epigenetics. Clinical Epigenetics
47
64
.
Fawaz Alzaïd, Tomas Jakobsson, Eckardt Treuter & Nicolas Venteclef. 2019. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics
233
263
.
Yuzhi Wang, Xue Lin, Xue Gong, Lele Wu, Jun Zhang, Weiguang Liu, Jian Li & Liming Chen. (2018) Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression. Oncogenesis 7:12.
Crossref
Crossref
Hamish W. King, Nadezda A. Fursova, Neil P. Blackledge & Robert J. Klose. (2018) Polycomb repressive complex 1 shapes the nucleosome landscape but not accessibility at target genes. Genome Research 28:10, pages 1494-1507.
Crossref
Crossref
Pasano BojangJr.Jr. & Kenneth S. Ramos. (2018)
Epigenetic reactivation of
LINE
‐1 retrotransposon disrupts Nu
RD
corepressor functions and induces oncogenic transformation in human bronchial epithelial cells
. Molecular Oncology 12:8, pages 1342-1357.
Crossref
Crossref
Fawaz Alzaïd, Tomas Jakobsson, Eckardt Treuter & Nicolas Venteclef. 2017. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics
1
31
.
Jovylyn Gatchalian, Xiaodong Wang, Jinzen Ikebe, Khan L. Cox, Adam H. Tencer, Yi Zhang, Nathaniel L. Burge, Luo Di, Matthew D. Gibson, Catherine A. Musselman, Michael G. Poirier, Hidetoshi Kono, Jeffrey J. Hayes & Tatiana G. Kutateladze. (2017) Accessibility of the histone H3 tail in the nucleosome for binding of paired readers. Nature Communications 8:1.
Crossref
Crossref
Adam H. Tencer, Khan L. Cox, Luo Di, Joseph B. Bridgers, Jie Lyu, Xiaodong Wang, Jennifer K. Sims, Tyler M. Weaver, Hillary F. Allen, Yi Zhang, Jovylyn Gatchalian, Michael A. Darcy, Matthew D. Gibson, Jinzen Ikebe, Wei Li, Paul A. Wade, Jeffrey J. Hayes, Brian D. Strahl, Hidetoshi Kono, Michael G. Poirier, Catherine A. Musselman & Tatiana G. Kutateladze. (2017) Covalent Modifications of Histone H3K9 Promote Binding of CHD3. Cell Reports 21:2, pages 455-466.
Crossref
Crossref
Mary Ellen Urick, Meghan L. Rudd & Daphne W. Bell. 2017. Precision Molecular Pathology of Uterine Cancer. Precision Molecular Pathology of Uterine Cancer
87
122
.
Diego E. Montoya-Durango, Kenneth A. Ramos, Pasano Bojang, Lorell Ruiz, Irma N. Ramos & Kenneth S. Ramos. (2016) LINE-1 silencing by retinoblastoma proteins is effected through the nucleosomal and remodeling deacetylase multiprotein complex. BMC Cancer 16:1.
Crossref
Crossref
Barbora Malecova, Alessandra Dall'Agnese & Pier Lorenzo Puri. (2016) Muscles cannot break a NuRDy heart. The EMBO Journal 35:15, pages 1600-1602.
Crossref
Crossref
Kathleen H. Wood & Zhaolan Zhou. (2016) Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation. Frontiers in Genetics 7.
Crossref
Crossref
J.C. Eissenberg. 2016. Chromatin Signaling and Diseases. Chromatin Signaling and Diseases
113
125
.
Abrey J Yeo, Olivier J Becherel, John E Luff, Mark E Graham, Derek Richard & Martin F Lavin. (2015) Senataxin controls meiotic silencing through ATR activation and chromatin remodeling. Cell Discovery 1:1.
Crossref
Crossref
Qian Du, Phuc-Loi Luu, Clare Stirzaker & Susan J Clark. (2015) Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics 7:6, pages 1051-1073.
Crossref
Crossref
Venkatadri KollaKoumudi NaraparajuTiangang ZhuangMayumi HigashiSriharsha KollaGerd A. BlobelGarrett M. Brodeur. (2015) The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex. Biochemical Journal 468:2, pages 345-352.
Crossref
Crossref
James Hagman. 2015. Molecular Biology of B Cells. Molecular Biology of B Cells
35
53
.
Jovylyn Gatchalian & Tatiana G. Kutateladze. 2015. Histone Recognition. Histone Recognition
27
47
.
Carissa Dege & James Hagman. (2014) Mi-2/NuRD chromatin remodeling complexes regulate B and T-lymphocyte development and function. Immunological Reviews 261:1, pages 126-140.
Crossref
Crossref
Sören Boller & Rudolf Grosschedl. (2014) The regulatory network of B‐cell differentiation: a focused view of early B‐cell factor 1 function. Immunological Reviews 261:1, pages 102-115.
Crossref
Crossref
Wangzhi Li & Alea A Mills. (2014) Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes. Epigenomics 6:4, pages 381-395.
Crossref
Crossref
Saad S.M. Alqarni, Andal Murthy, Wei Zhang, Marcin R. Przewloka, Ana P.G. Silva, Aleksandra A. Watson, Sara Lejon, Xue Y. Pei, Arne H. Smits, Susan L. Kloet, Hongxin Wang, Nicholas E. Shepherd, Philippa H. Stokes, Gerd A. Blobel, Michiel Vermeulen, David M. Glover, Joel P. Mackay & Ernest D. Laue. (2014) Insight into the Architecture of the NuRD Complex. Journal of Biological Chemistry 289:32, pages 21844-21855.
Crossref
Crossref
Scott B. Rothbart & Brian D. Strahl. (2014) Interpreting the language of histone and DNA modifications. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1839:8, pages 627-643.
Crossref
Crossref
Guoqiang Zhang & Sriharsa Pradhan. (2014) Mammalian epigenetic mechanisms. IUBMB Life 66:4, pages 240-256.
Crossref
Crossref
Claire Westerland & Tom C. Karagiannis. 2014. Molecular mechanisms and physiology of disease. Molecular mechanisms and physiology of disease
81
112
.
Christopher J Millard, Peter J Watson, Louise Fairall & John W R Schwabe. (2013) An evolving understanding of nuclear receptor coregulator proteins. Journal of Molecular Endocrinology 51:3, pages T23-T36.
Crossref
Crossref
Hillary F. Allen, Paul A. Wade & Tatiana G. Kutateladze. (2013) The NuRD architecture. Cellular and Molecular Life Sciences 70:19, pages 3513-3524.
Crossref
Crossref